Autonomous dose determination for pen delivery of medicament
OwnerMichael J. Rosinko, Himanshu Patel +1inventors
InventorsMichael J. Rosinko, Himanshu Patel, Firas H. El-Khatib
Life of this patent
Estimating the term…
Loading patent…
OwnerMichael J. Rosinko, Himanshu Patel +1inventors
InventorsMichael J. Rosinko, Himanshu Patel, Firas H. El-Khatib
Estimating the term…
A glucose level control system may be configured to determine a recommended medicament dose based at least in part on a subject's therapy data and/or user-specified medicament related inputs. The therapy data may include glucose level data and medicament delivery data. The user-specified medicament related inputs may include qualitative meal announcements. For example, the user can specify that the subject consumed a small, medium, or large meal. The glucose level control system may be configured to output an indication of the recommended medicament dose to a display. The glucose level control system may be configured to output a dose control signal to preconfigure a smart pen to deliver the recommended medicament dose. The glucose level control system may be configured to generate an alert if it determines, based at least in part on glucose level data and/or medicament delivery data associated with the subject, that trigger criteria have been satisfied.
A glucose level control system configured to generate glucose control therapy recommendations for controlling a glucose level of a subject, the glucose level control system comprising:
Dependencies are inferred from the claim text.